BC
PRCT icon

Brookfield Corp’s Procept Biorobotics PRCT Stock Holding History

Brookfield Corp’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,702
Closed -$872K – 723
2023
Q1 		$872K Sell
30,702
-11,319
-27% -$399K ﹤0.01% 526
2022
Q4 		$1.75M Sell
42,021
-1,995
-5% -$85.7K 0.01% 431
2022
Q3 		$1.82M Buy
+44,016
New +$1.76M 0.01% 473

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Brookfield Corp's PRCT Position: Q2 2023 in Review

Brookfield Corp sold out of Procept Biorobotics (PRCT) in Q2 2023, closing a stake of 30,702 shares — an estimated $872K sold.

Brookfield Corp first reported a position in PRCT in Q3 2022 and held it in 3 quarters. The position peaked at $1.82M in Q3 2022. 120 funds tracked by Wall St. Rank hold PRCT as of Q2 2023.

  • Brookfield Corp reported no remaining Procept Biorobotics position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 30,702 Procept Biorobotics shares in Q2 2023, an estimated $872K.
  • Brookfield Corp first reported a position in Procept Biorobotics in Q3 2022 and held it in 3 quarters.
  • Brookfield Corp's Procept Biorobotics position peaked at $1.82M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.